期刊文献+

Atrogin-1基因在贲门腺癌组织中的表达及其异常甲基化

Expression and aberrant methylation of atrogin-1 gene in gastric cardia adenocarcinoma tissuse
原文传递
导出
摘要 目的:探讨atrogin-1基因在贲门腺癌(gastric cardia adenocarcinoma,GCA)中的异常甲基化及表达,并分析其临床意义。方法: 选用河北医科大学第四医院2004—2008年间的贲门腺癌患者手术标本共139例,分别应用亚硫酸氢盐转换-甲基化特异性PCR(bisulfite conversion-methylation specific polymerase chain reaction,BS-MSP)、RT-PCR和免疫组织化学法检测贲门腺癌组织及相应癌旁(距癌灶边缘3~5 cm)组织中atrogin-1基因的甲基化、mRNA和蛋白表达情况,应用免疫组织化学法检测相应组织中Smad4蛋白的表达。结果: 贲门腺癌组织中atrogin-1基因启动子区的甲基化率[44.6%(62/139)] 显著高于癌旁组织[3.6%(5/139)](χ^2=63.891,P=0.001),且atrogin-1基因的甲基化与TNM分期及肿瘤的组织学分化程度密切相关(χ^2=6.144, P〈0.05)。贲门腺癌组织中atrogin-1基因的mRNA和蛋白表达水平显著低于癌旁组织[(0.482 5±0.175 4) vs (0.896 9±0.290 1),t=10.62, P=0.01;34.5% vs 82.0%, χ^2=4.441,P=0.001],且与其启动子区的甲基化状态之间有明显的相关性(r=-0.256,P=0.001)。贲门腺癌组织中Smad4蛋白表达的阳性率显著低于癌旁组织(46.0% vs 95.7%; χ^2=2.945,P=0.001),且与atrogin-1蛋白表达之间呈明显的正相关(r=0.604,P=0.001)。结论: Atrogin-1基因启动子区高甲基化导致的基因沉默可能是贲门癌组织中此基因表达降低的机制之一。 Objective : To investigate the expression and aberrant methylation of the atrogin-1 gene in gastric cardia adenocarcinoma (GCA). Methods: Tumor and normal tissue samples were collected from GCA patients ( n =139) undergoing surgical treatment in the Fourth Hospital of Hebei Medical University between 2004 and 2008. DNA methylation in the atrogin-1 promoter was analyzed by bisulfite conversion-methylation specific polymerase chain reaction (BS-MSP), atrogin-1 mRNA abundance by RT-PCR, and density of immunoreactive signals for atrogin-1 and Smad4 by immunohistochemical staining. Results: The frequency of aberrant DNA methylation in the promoter region of atrogin-1 was significantly higher inGCA than in normal tissues (44.6% vs 3.6%, P 〈0.05). The methylation status of atrogin-1 in tumor tissues was associated with TNM stage and the degree of histological differentiation of the tumor ( P 〈0.05). The mRNA and protein levels of atrogin-1 were significantly decreased in tumor tissues as compared with normal tissues (0.482 5±0.175 4 vs 0.896 9±0.290 1 and 34.5% vs 82.0%, respectively, P 〈0.01). there was a negative correlation between atrogin-1 methylation and atrogin-1 mRNA and protein levels ( r =-0.256, P 〈0.01). Smad4 protein was detected in 46.0% of tumor tissues but in 95.7% of non-tumor tissue ( P 〈0.01) and the protein level of smad4 was positively associated with that of atrogin-1 ( r =0604, P 〈0.01). Conclusion: Hypermethylation in the promoter region of the atrogin-1 gene and the resultant decrease in atrogin-1 protein synthesis may play an important role in the pathogenesis of gastric cardia adenocarcinoma.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2014年第1期67-72,共6页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.81101854)~~
关键词 贲门腺癌 ATROGIN-1 甲基化 表达 gastric cardia adenocarcinoma atrogin-1 methylation expression
  • 相关文献

参考文献14

  • 1Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy [J]. Science, 2001, 294(5547) : 1704-1708.
  • 2Hanai J, Cao P, Tanksale P, et al. The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity [J]. J Clin Invest, 2007, 117(12) : 3940-3951.
  • 3Stitt TN, Drujan D, Clarke BA, et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors [ J]. Mol Cell, 2004, 14(3) :395-403.
  • 4Tan J, Yang X, Zhuang L, et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells [ J]. Genes Dev, 2007, 21(9) : 1050-1063.
  • 5Qin H, Chan MW, Liyanarachchi S, et al. An integrative ChiP-chip and gene expression profiling to model SMAD regulatory modules [J]. BMC Syst Biol, 2009, 3(1 ) : 73.
  • 6Chou JL, Su HY, Chen LY, et al. Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer [J]. Lab Invest, 2010, 90(3): 414-425.
  • 7张清泉,董稚明,郭炜,张明慧,崔蕾.GADD45A基因在人贲门腺癌组织中的异常甲基化和表达及其临床意义[J].中国肿瘤生物治疗杂志,2013,20(3):317-322. 被引量:1
  • 8Sasaki M, Anast J, Bassett W, et al. Bisulfite conversion-specific and methylation-specific PCR: A sensitive technique for accurate evaluation of CpG methylation [J]. Biochem Biophys Res Commnn, 2003, 309(2): 305-309.
  • 9Li HH, Kedar V, Zhang C, et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex [J~. J Clin Invest, 2004, 114(8); 1058-1071.
  • 10Li J J, Zhang TP, Meng Y, et al. Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 ceils [J]. Cell Physiol Biochem, 2011, 27(5) : 463-470.

二级参考文献20

  • 1Fomace AJ Jr , Alamo I Jr, Hollander MC. DNA damage?inducible transcripts in mammalian cells [J]. Proc Nat! Acad Sci USA, 1988, 85 (23) : 8800-8804.
  • 2Rosemary Siafakas A, Richardson DR. Growth arrest and DNA damage45 alpha (GADD45alpha) [J]. Int J Biochem Cell Bioi, 2009, 41 (5) : 986-989.
  • 3Cretu A, Sha X, Tront J, et al. Stress sensor Gadd45 genes as therapeutic targets in cancer [J]. Cancer Ther, 2009, 7 ( A) : 268-276.
  • 4Wang W, Huper G, Guo Y, et al. Analysis of methylation-sensi?tive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer [J]. Oncogene, 2005, 24 (16 ): 2705- 2714.
  • 5Ramachandran K, Gopisetty G, Gordian E, et al. Methylation?mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target [J]. Cancer Res, 2009, 69 (4): 1527-1535.
  • 6Higashi H, Vallbohmer D, Wamecke-Eberz U, et al. Down-regu?lation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer [J]. Anticancer Res, 2006, 26 (3A) : 2143-2147.
  • 7Wang Bx, Yin BL, He B, et ai, Overexpression of DNA damage?induced 45 (l gene contributes to esophageal squamous cell cancer by promoter hypomethylation [J]. J Exp Clin Cancer Res, 2012, 31: 11.
  • 8Schneider G, Weber A, Zechner U, et al. GADD45alpha is highly expressed in pancreatic ductal adenocarcinoma cells and re?quired for tumor cell viability [J]. Int J Cancer, 2006, 118 (10) : 2405-2411.
  • 9Reddy SP, Britto R, Vinnakota K, et al. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis [J]. Clin Cancer Res, 2008, 14 ( 10) : 2978-2987.
  • 10Yamasawa K, Nio Y, Dong M, et al. Clinicopathological signifi?cance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer [J]. Clin Cancer Res, 2002, 8 (8) : 2563-2569.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部